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The following errors appeared in this article. The authors apologize for these errors.
 Page 1240, Abstract, Results, Line 7: “(hazard ratio: 1.88, 95% conﬁdence interval: 1.33 to 2.66; p < 0.001)” should
have been “(hazard ratio: 1.84, 95% conﬁdence interval: 1.30 to 2.61; p ¼ 0.001)”.
 Page 1240, Abstract, Results, Line 8: “There was a signiﬁcant, albeit weaker association with nonfatal myocardial
infarction “(hazard ratio: 1.44, 95% conﬁdence interval: 1.03 to 2.01; p ¼ 0.031)” should have been “There was a weaker
association with nonfatal myocardial infarction “(hazard ratio: 1.37, 95% conﬁdence interval: 0.98 to 1.92; p ¼ 0.066)”
 Page 1241, Column 2, Paragraph 1, Line 21: “ethylenediamine-tetraacetic-acid plasma samples available for
measurement of high-sensitivity cTnT (hs-TnT) and”, should have been deleted so it would read: “All patients who had
baseline serum samples available for determination for high-sensitivity cTnI (hs-TnI) (n ¼ 3,623).”
 “ejection fraction <50%” should be “ejection fraction 50%” and “LVEF <50%” should be “LVEF 50%” throughout.
This includes Tables 1 to 5, and the following locations in the text:
 Page 1242, Column 1, Paragraph 3, Line 25: “ejection fraction <50%” should be “ejection fraction 50%”;
 Page 1243, Column 1, Paragraph 1, Line 4: “ejection fraction <50%” should be “ejection fraction 50%”;
 Page 1243, Column 2, Paragraph 1, Line 8: “ejection fraction <50%” should be “ejection fraction 50%”.
 Page 1242, Column 2, Results, Paragraph 1, Line 6: “105 patients (2.9%)” should have been “109 patients (3.0%)”.
 Page 1242, Column 2, Results, Paragraph 1, Line 10: “395 of 3,679” should have been “383 of 3,513”.
 Page 1242, Column 2, Results, Paragraph 3, Line 14: “(p ¼ 0.07)” should have been “(p ¼ 0.09)”.
 Page 1242, Column 2, Results, Paragraph 3, Line 18: “(p ¼ 0.12)” should have been “(p ¼ 0.15)”.
 Page 1243, Column 1, Paragraph 1, Line 2: “1.68, 95% conﬁdence interval [CI]: 1.54 to 1.84; p <0.0001” should have
been “1.66, 95% conﬁdence interval [CI]: 1.52 to 1.81; p <0.001”
 Page 1243, Column 1, Paragraph 1, Line 7: “stroke”, should have been inserted to read: ”. arterial claudication, stroke,
and use of lipid-lowering drugs.”
 Page 1243, Column 1, Paragraph 1, Line 9: “HR: 1.34, 95% CI: 1.19 to 1.51; p <0.0001” should have been “HR: 1.31,
95% CI: 1.17 to 1.47; p <0.001”
 Page 1243,Column1, Paragraph 2, Line 5: “.were 1.60 (95%CI: 1.42 to 1.81; p<0.0001) and 1.30 (95%CI: 1.10 to 1.52;
p¼ 0.002)” should have been “..were 1.59 (95%CI: 1.42 to 1.79; p<0.001) and 1.35 (95%CI: 1.16 to 1.57; p< 0.001)”.
 Page 1243, Column 1, Paragraph 2, Line 8: “1.86 (95% CI: 1.64 to 2.11; p <0.0001) and 1.42 (95% CI: 1.20 to 1.69;
p <0.0001)” should have been “1.80 (95% CI: 1.60 to 2.02; p <0.001) and 1.31 (95% CI: 1.11 to 1.54; p ¼ 0.001)”.
 Page 1243, Column 1, Paragraph 3, Line 6: “4.18 (95% CI: 3.15 to 5.54; p <0.0001)” should have been “4.20 (95% CI:
3.18 to 5.54; p <0.001”
 Page 1243, Column 1, Paragraph 3, Line 9: “HR: 2.12, 95% CI: 1.54 to 2.93; p <0.0001” should have been “HR: 2.18,
95% CI: 1.57 to 3.01; p <0.001”
 Page 1243, Column 1, Paragraph 3, Line 12: “2.01 (95% CI: 1.33 to 3.05; p ¼ 0.001) for cardiovascular death and 2.14
(95% CI: 1.32 to 3.49; p ¼ 0.002) for nonfatal heart failure” should have been “2.23 (95% CI: 1.48 to 3.36; p < 0.001)
for cardiovascular death and 2.09 (95% CI: 1.28 to 3.43; p ¼ 0.003) for nonfatal heart failure”
 Page 1243, Column 2, Paragraph 1, Line 6: “(HR: 1.30, 95% CI: 1.15 to 1.47; p < 0.0001)” should have been
“(HR: 1.24, 95% CI: 1.10 to 1.39; p < 0.001)”
 Page 1243,Column 2, Paragraph 1, Line 9: “coronary artery bypass grafting” should have been” use of lipid-lowering drugs”.
 Page 1243, Column 2, Paragraph 1, Line 11: “(HR: 1.20, 95% CI: 1.04 to 1.37; p ¼ 0.010)” should have been “(HR:
1.15, 95% CI: 1.00 to 1.31; p ¼ 0.049)”
 Page 1243, Column 2, Paragraph 1, Line 12: “Further adjustment for history of AMI did not alter the results” should
have been “Further adjustment for history of AMI attenuated the results slightly (p ¼ 0.088)”.
 Page 1243, Column 2, Paragraph 1, Line 15: “HR of 1.75 (95% CI: 1.31 to 2.35); after multivariate adjustment the HR
was 1.41 (95% CI: 1.03 to 1.94; p ¼ 0.034)” should have been “(HR: 1.68, 95% CI: 1.26 to 2.23); after multivariate
adjustment the HR was 1.35 (95% CI: 0.99 to 1.85; p ¼ 0.058)”
 Page 1243, Column 2, Paragraph 2, Line 3: “..entered as continuous or as dichotomous variables (at the 75th
percentile cut points,.” should have been “..entered as dichotomous variables (at the 75th percentile cut points,.”
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196 Page 1243, Column 2, Paragraph 2, Line 7: “For the endpoint of nonfatal AMI, the association was highly signiﬁcant for hs-
TnI, but not for hs-TnT(Table 4)” shouldhavebeen “For the end-point of nonfatalAMI, the associationwas signiﬁcant forhs-
TnI as a continuous, but not as a dichotomous variable, while no association with AMI was observed for hs-TnT (Table 4).”
 Page 1243, Column 2, Paragraph 3, Line 4: “.the association remained highly signiﬁcant after multivariate adjustment
(HR: 1.96; 95% CI: 1.40 to 2.74; p < 0.0001)” should have been “.the association was no longer signiﬁcant after
multivariate adjustment (HR: 1.21; 95% CI: 0.69 to 2.11; p ¼ 0.508)”
 Page 1245, Column 1, Paragraph 1, Line 2: “, the association was attenuated and borderline signiﬁcant (HR: 1.43; 95%
CI: 1.00 to 2.05], p ¼ 0.051)” should have been “.the association was highly signiﬁcant (HR: 1.71; 95% CI: 1.19 to
2.46; p ¼ 0.004 (Table 5).”
 Page 1245, Column 1, Paragraph 2, Line 16; “(HR: 7.57; 95% CI: 4.30 to 13.35)” should have been “(HR: 7.64; 95%
CI: 4.33 to 13.46)”
 Page 1245, Column 1, Paragraph 2, Line 19: “(HR: 2.25; 95% CI: 1.18 to 4.28)” should have been “(HR: 2.25; 95% CI:
1.18 to 4.29)”
 Page1245,Column2,Paragraph1,Line1: “0.763 (95%CI: 0.725 to0.801)” shouldhavebeen “0.775 (95%CI: 0.740 to0.810)”
 Page 1245, Column 2, Paragraph 1, Line 2: “Adding hs-TnI to the model resulted in a small, but signiﬁcant increase in
the C-index (Table 7)” should have been “Adding hs-TnI as a continuous variable to the model resulted in a small, but
signiﬁcant increase in the C-index (Table 7).”
 Page1245,Column2,Paragraph1,Line6: “0.647 (95%CI: 0.597 to0.696)” shouldhavebeen “0.644 (95%CI: 0.604 to0.684)”
 Page 1245, Column 2, Paragraph 2, Line 2: “categorical” should have been inserted and “highly” should have been
deleted, to read: “Adding categorical hs-TnI to the models resulted in signiﬁcant.”
 Page 1245, Column 2, Paragraph 3, Last Line: “(HR: 0.84; 95% CI: 0.59 to 1.21; p ¼ 0.35)” should have been “(HR:
0.70; 95% CI: 0.45 to 1.10; p ¼ 0.12).”
 Page 1246, Column 2, Line 3: “as a continuous variable” should have been inserted, to read: “Furthermore, hs-TnI as
a continuous variable, but not hs-TnT..”
 Page 1248, Column 1, Paragraph 1, Line 9: “as a continuous variable”, should have been inserted, to read: “Moreover,
the ﬁnding that hs-TnI as a continuous variable, but not hs-TnT.”
 Page 1248, Column 2, Last Line: “as a continuous variable” should have been inserted, to read: “Notably, hs-TnI as
a continuous variable, but not hs-TnT.”
 Figure 2: In the corrected Figure 2 the categorization of patients into quartiles is unchanged, but the timing of some the
events differ from the original version.
 Table 3 and Table 4, Footnote: “troponin” should have been replaced with “biomarker”, to read “HRs based on a 1 SD
change in the natural logarithm of biomarker concentration”
 Table 5, Footnote: “HRs based on a 1 SD change in the natural logarithm of biomarker concentration” should have
been inserted.
 The corrected tables are printed below.igure 2 Cumulative Incidence of Cardiovascular Death or Heart Failure by Quartiles of hs-TnI
Table 1 Patient Characteristics by Quartile of hs-TnI
Quartile 1 Quartile 2 Quartile 3 Quartile 4
p Value
for trend
Total No. of
Patients Value
Total No. of
Patients Value
Total No. of
Patients Value
Total No. of
Patients Value
hs-TnI, pg/ml
Men 743 1.2–3.0 748 3.1–4.5 710 4.6–7.3 732 7.4–610.1
Women 180 1.2–2.5 166 2.6–3.9 176 4.0–6.3 168 6.4–577.1
Demographic characteristics
Age, yrs 923 61.7  7.4 914 63.9  7.9 886 65.0  8.3 900 66.0  8.4 <0.001
Female 923 180 (19.5) 914 166 (18.2) 886 176 (19.9) 900 168 (18.7) 0.887
Body mass index, kg/m2 917 28.1  4.5 910 28.3  4.4 878 28.7  5.0 899 29.1  4.9 <0.001
Medical history
Documented myocardial
infarction
923 425 (46.0) 914 509 (55.7) 885 560 (63.3) 900 554 (61.6) <0.001
Angina pectoris 923 694 (75.2) 914 663 (72.5) 885 639 (72.2) 900 645 (71.7) 0.097
Percutaneous coronary
intervention
922 464 (50.3) 914 429 (46.9) 885 420 (47.5) 900 343 (38.1) <0.001
Coronary artery bypass grafting 923 256 (27.7) 914 286 (31.3) 885 341 (38.5) 900 394 (43.8) <0.001
Diabetes mellitus 923 135 (14.6) 914 127 (13.9) 885 142 (16.0) 900 179 (19.9) 0.001
Previous hypertension 923 325 (35.2) 914 373 (40.8) 885 425 (48.0) 900 479 (53.2) <0.001
Intermittent claudication 923 63 (6.8) 914 70 (7.7) 885 91 (10.3) 900 95 (10.6) 0.001
TIA 923 25 (2.7) 914 32 (3.5) 885 24 (2.7) 900 36 (4.0) 0.238
Stroke 923 25 (2.7) 914 36 (3.9) 885 44 (5.0) 899 50 (5.6) 0.001
Current smoker 923 143 (15.5) 913 145 (15.9) 884 130 (14.7) 900 125 (13.9) 0.260
Mean blood pressure, mm Hg
Systolic 921 129.7  15.2 914 131.5  16.3 885 135.3  17.0 900 137.2  17.5 <0.001
Diastolic 921 77.8  9.7 914 77.6  10.0 885 78.6  9.8 900 78.6  10.2 0.009
Laboratory determinations
LVEF 50% 887 154 (17.4) 891 195 (21.9) 866 246 (28.4) 883 277 (31.4) <0.001
eGFR, ml/min/1.73 m2 922 81.9  19.8 914 78.1  17.7 883 77.0  19.3 897 75.1  19.8 <0.001
Serum cholesterol, mg/dl 897 190.4  39.3 875 193.0  38.3 844 190.6  38.5 862 193.9  38.9 0.131
CRP, mg/l (95% CI)* 917 1.5 (1.4–1.6) 907 1.7 (1.5–1.8) 878 1.8 (1.7–1.9) 892 2.1 (1.9–2.2) <0.001
NT-proBNP, pg/ml (95% CI)* 917 84.5 (80.1–89.1) 903 114.9 (108.5–121.7) 876 169.2 (159.2–179.7) 890 254.4 (237.9–272.1) <0.001
hs-TnT, pg/ml 904 4.9  4.1 879 5.8  4.7 857 7.8  4.7 873 11.7  8.7 <0.001
Medications
Assignment to trandolapril 923 453 (49.1) 914 468 (51.2) 886 440 (49.7) 900 449 (49.9) 0.900
Calcium-channel blocker 923 304 (32.9) 914 312 (34.1) 885 290 (32.8) 899 298 (33.1) 0.920
Beta-blocker 923 567 (61.4) 914 579 (63.3) 885 544 (61.5) 899 555 (61.7) 0.898
Aspirin or other antiplatelet
medication
923 855 (92.6) 914 844 (92.3) 885 810 (91.5) 899 799 (88.9) 0.004
Lipid-lowering drug 923 712 (77.1) 914 649 (71.0) 885 635 (71.8) 898 603 (67.1) <0.001
*Values are range, mean  SD, n (%) or geometric means (95% conﬁdence intervals).
CRP ¼ C-reactive protein; hs-TnT ¼ high-sensitivity cardiac troponin T; eGFR ¼ estimated glomerular ﬁltration rate; hs-TnI ¼ high-sensitivity cardiac troponin I; LVEF ¼ left ventricular ejection fraction; NT-proBNP ¼ N-terminal pro–B-type natriuretic peptide; TIA ¼ transient
ischemic attack.
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Table 2 Predictors of Circulating hs-Tnl and hs-TnT
Determinant
Univariate Analysis Multivariate Analysis*
hs-TnI: Standardized
Beta (p)
hs-TnT: Standardized
Beta (p)
hs-TnI: Standardized
Beta (p)
hs-TnT: Standardized
Beta (p)
Treatment assignment at baseline 0.003 (0.845) 0.029 (0.088)
Age 0.166 (<0.001) 0.325 (<0.001) 0.037 (0.032) 0.239 (<0.001)
Male 0.093 (<0.001) 0.176 (<0.001) 0.164 (<0.001) 0.248 (<0.001)
BMI 0.074 (<0.001) 0.044 (0.009) 0.113 (<0.001) 0.096 (<0.001)
LVEF 50% 0.114 (<0.001) 0.079 (<0.001) 0.023 (0.140)
eGFR 0.107 (<0.001) 0.155 (<0.001) 0.023 (0.151) 0.053 (0.001)
Current smoking 0.028 (0.089) 0.120 (<0.001) 0.044 (0.004)
Previous hypertension 0.119 (<0.001) 0.106 (<0.001) 0.084 (<0.001) 0.062 (<0.001)
Documented myocardial infarction 0.117 (<0.001) 0.005 (0.781) 0.086 (<0.001)
Diabetes mellitus 0.052 (0.002) 0.121 (<0.001) 0.034 (0.026) 0.113 (<0.001)
Intermittent claudication 0.055 (0.001) 0.057 (0.001)
TIA 0.014 (0.417) 0.025 (0.147)
Stroke 0.057 (0.001) 0.066 (<0.001)
PCI 0.094 (<0.001) 0.103 (<0.001) 0.033 (0.038) 0.043 (0.004)
CABG 0.130 (<0.001) 0.134 (<0.001) 0.033 (0.046)
Total cholesterol 0.017 (0.315) 0.057 (0.001)
Use of beta-blockers 0.002 (0.929) 0.027 (0.110)
Use of lipid-lowering drugs 0.076 (<0.001) 0.058 (0.001)
Use of aspirin and antiplatelet medications 0.060 (<0.001) 0.074 (<0.001)
CRP 0.094 (<0.001) 0.046 (0.006) 0.034 (0.035)
NT-proBNP 0.389 (<0.001) 0.298 (<0.001) 0.376 (<0.001) 0.234 (<0.001)
hs-TnT 0.443 (<0.001)
hs-TnI 0.443 (<0.001)
*Final models for logarithmically transformed hs-TnI and hs-TnT. Variables identiﬁed in univariate analyses with p <0.20 were entered into the multivariate model, which was further reduced by the F-ratio
test. Multivariate models thus differ for hs-Tnl and hs-TnT. Determination coefﬁcients (r2 values) for models for hs-TnI and hs-TnT were 0.461 and 0.483, respectively.
BMI ¼ body mass index; CABG ¼ coronary artery bypass grafting; PCI ¼ percutaneous coronary intervention; other abbreviations and units as in Table 1.
Table 3
Final Multivariable Cox Regression Models for Cardiovascular Death or
Congestive Heart Failure
Variable
Fourth Quartile for hs-TnI and hs-TnT Continuous hsTnI and hs-TnT
HR (95% CI) p Value HR (95% CI) p Value
hs-TnI 1.84 (1.30–2.61) 0.001 1.13 (0.98–1.30)* 0.096
hs-TnT 1.47 (1.03–2.09) 0.033 1.57 (1.22–2.02)* <0.001
Age 1.04 (1.02–1.07) <0.0001 1.04 (1.01–1.06) 0.001
LVEF 50% 1.22 (0.89–1.67) 0.23 1.19 (0.86–1.63) 0.293
eGFR 1.00 (0.99–1.00) 0.36 1.00 (0.99–1.01) 0.450
Current smoking 1.61 (1.08–2.42) 0.020 1.58 (1.06–2.37) 0.025
History of hypertension 1.22 (0.90–1.67) 0.21 1.25 (0.92–1.71) 0.149
History of myocardial infarction 1.16 (0.85–1.59) 0.35 1.14 (0.83–1.57) 0.414
History of diabetes mellitus 1.77 (1.26–2.47) 0.001 1.71 (1.22–2.39) 0.002
History of CABG 1.26 (0.93–1.71) 0.135 1.20 (0.88–1.63) 0.245
Serum total cholesterol 1.00 (1.00–1.01) 0.030 1.00 (1.00–1.01) 0.014
History of intermittent claudication 1.64 (1.12–2.41) 0.012 1.53 (1.03–2.26) 0.033
History of stroke 1.31 (0.79–2.18) 0.288 1.29 (0.78–2.13) 0.329
Lipid-lowering therapy 0.67 (0.49–0.91) 0.009 0.66 (0.49–0.90) 0.009
NT-proBNP 1.50 (1.26–1.78)* <0.0001 1.55 (1.30–1.84)* <0.0001
CRP 1.05 (0.90–1.22)* 0.55 1.04 (0.89–1.21)* 0.619
*HRs based on a 1-SD change in the natural logarithm of biomarker concentration.
CI ¼ conﬁdence interval; HR ¼ hazard ratio; other abbreviations and units as in Tables 1 and 2.
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Table 4 Final Multivariable Cox Regression Models for Myocardial Infarction
Variable
Fourth Quartile for hs-TnI and hs-TnT Continuous hs-TnI and hs-TnT
HR (95% CI) p Value HR (95% CI) p Value
hs-TnI 1.37 (0.98–1.92) 0.066 1.17 (1.01–1.36)* 0.037
hs-TnT 1.03 (0.72–1.46) 0.876 1.00 (0.84–1.18)* 0.967
Age 1.02 (1.00–1.04) 0.107 1.02 (1.00–1.04) 0.100
LVEF 50% 1.38 (1.01–1.88) 0.040 1.37 (1.01–1.86) 0.046
Current smoking 1.81 (1.28–2.58) 0.001 1.81 (1.28–2.58) 0.001
History of hypertension 1.28 (0.96–1.71) 0.088 1.28 (0.97–1.71) 0.086
History of diabetes mellitus 1.60 (1.15–2.23) 0.005 1.61 (1.16–2.24) 0.004
Lipid lowering therapy 0.75 (0.56–1.01) 0.057 0.76 (0.56–1.02) 0.064
NT–proBNP 0.99 (0.84–1.16)* 0.858 0.97 (0.83–1.15)* 0.759
CRP 1.16 (1.01–1.34)* 0.039 1.16 (1.01–1.34)* 0.041
*HRs based on a 1-SD change in the natural logarithm of biomarker concentration.
Abbreviations and units as in Tables 1 to 3.
Table 5
Final Multivariable Cox Regression Models for Cardiovascular Death or
Congestive Heart Failure Dichotomized at Sex-Speciﬁc 99th Percentile of
Healthy Subjects
Variable
>99th Percentile for hs-TnI and hs-TnT
HR (95% CI) p Value
hsTnI 1.21 (0.69–2.11) 0.508
hs-TnT 1.71 (1.19–2.46) 0.004
Age 1.04 (1.02–1.07) <0.0001
LVEF 50% 1.24 (0.90–1.71) 0.18
eGFR 1.00 (0.99–1.01) 0.42
Current smoking 1.58 (1.05–2.36) 0.028
History of hypertension 1.31 (0.96–1.78) 0.084
History of myocardial infarction 1.20 (0.87–1.64) 0.268
History of diabetes mellitus 1.77 (1.26–2.48) 0.001
History of CABG 1.29 (0.95–1.75) 0.104
Serum total cholesterol 1.00 (1.00–1.01) 0.026
History of intermittent claudication 1.62 (1.10–2.40) 0.015
History of stroke 1.31 (0.79–2.18) 0.296
Lipid-lowering therapy 0.65 (0.48–0.88) 0.006
NT-proBNP* 1.65 (1.40–1.96) <0.0001
CRP* 1.06 (0.91–1.24) 0.46
*HRs based on a 1-SD change in the natural logarithm of biomarker concentration.
Abbreviations and units as in Tables 1 to 3.
Table 6 Risk Associated With Concordant or Discordant Levels of hs-TnI and hs-TnT
Variable N
Cardiovascular Death or Heart
Failure Myocardial Infarction
HR (95% CI) p Value HR (95% CI) p Value
TnI low & TnT low (reference category) 942
(TnI high&TnT low)OR (TnI low&TnThigh) 1,048 2.25 (1.18–4.29) 0.014 0.92 (0.63–1.33) 0.648
TnI high & TnT high 1,509 7.64 (4.33–13.46) <0.001 1.03 (0.74–1.45) 0.849
“High” deﬁned as greater or equal to the sex-speciﬁc 75th percentile of healthy subjects (hs-TnI: 4.2 pg/ml in men, 2.8 pg/ml in women; hs-TnT: 5.6
pg/ml in men, 3.9 pg/ml in women). “Low” deﬁned as lower than the sex-speciﬁc 75th percentile of healthy subjects.
Abbreviations as in Tables 1 to 3.
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Table 7
C-Index and Integrated Discrimination Index: Effect of Adding hs-TnI and hs-TnT to Multivariable Models for Cardiovascular Death
or Heart Failure
Variable
Dichotomous hs-TnI
and hs-TnT
Continuous hs-TnI
and hs-TnT
Variable
Dichotomous hs-TnI
and hs-TnT
Continuous hs-TnI
and hs-TnT
C-Index (95% CI) p Value C-Index (95% CI) p Value IDI p Value IDI p Value
Multivariable
model
without
hs-TnI/hs-TnT
0.775 (0.740–0.810) NA 0.775 (0.740–0.810) NA
hs-TnI 0.786 (0.753–0.820) 0.084 0.786 (0.752–0.820) 0.041 hs-Tnl 0.010 (0.001–0.024) 0.02 0.005 (0.002–0.021) 0.21
hs-TnT 0.781 (0.746–0.815) 0.230 0.790 (0.756–0.824) 0.026 hs-TnT 0.007 (0.001–0.021) 0.01 0.014 (0.004–0.032) <0.001
IDI ¼ integrated discrimination improvement; NA ¼ not applicable; other abbreviations as in Tables 1 to 3.
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